CatalystEarnings

$JAZZ. JAZZ PHARMACEUTICALS PLC

JAZZ

$229.74

+7.13%

What changed

FQ3 FY2026 (ends Sep) | reported Nov 02: - Revenue: $1.24B - Adj EPS: $-7.48 vs $-2.21 ⚠️ one-time - GAAP op margin: -33.3% (📉 -38.4pp YoY) Guidance (company): - FY2026 guidance, fiscal year ending Dec 31 revenue: $4.60B-$4.75B

Why it matters

FQ3 FY2026 (ends Sep) | reported Nov 02:

Sources

sec